Annexes to COM(2023)122 - Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
dossier | COM(2023)122 - Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland. |
---|---|
document | COM(2023)122 ![]() |
date | June 14, 2023 |
(4) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67).
(5) Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1).
(6) Commission Delegated Regulation (EU) 2016/161 of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use (OJ L 32, 9.2.2016, p. 1).
(7) OJ L 123, 12.5.2016, p. 1.